PMID- 25940691 OWN - NLM STAT- MEDLINE DCOM- 20160223 LR - 20220310 IS - 2045-2322 (Electronic) IS - 2045-2322 (Linking) VI - 5 DP - 2015 May 5 TI - Systematic optimization of human pluripotent stem cells media using Design of Experiments. PG - 9834 LID - 10.1038/srep09834 [doi] LID - 9834 AB - Human pluripotent stem cells (hPSC) are used to study the early stages of human development in vitro and, increasingly due to somatic cell reprogramming, cellular and molecular mechanisms of disease. Cell culture medium is a critical factor for hPSC to maintain pluripotency and self-renewal. Numerous defined culture media have been empirically developed but never systematically optimized for culturing hPSC. We applied design of experiments (DOE), a powerful statistical tool, to improve the medium formulation for hPSC. Using pluripotency and cell growth as read-outs, we determined the optimal concentration of both basic fibroblast growth factor (bFGF) and neuregulin-1 beta 1 (NRG1beta1). The resulting formulation, named iDEAL, improved the maintenance and passage of hPSC in both normal and stressful conditions, and affected trimethylated histone 3 lysine 27 (H3K27me3) epigenetic status after genetic reprogramming. It also enhances efficient hPSC plating as single cells. Altogether, iDEAL potentially allows scalable and controllable hPSC culture routine in translational research. Our DOE strategy could also be applied to hPSC differentiation protocols, which often require numerous and complex cell culture media. FAU - Marinho, Paulo A AU - Marinho PA AD - University of California San Diego, School of Medicine, Department of Pediatrics/Rady Children's Hospital San Diego, Department of Cellular &Molecular Medicine, Stem Cell Program, La Jolla, CA 92093, MC 0695, USA. FAU - Chailangkarn, Thanathom AU - Chailangkarn T AD - University of California San Diego, School of Medicine, Department of Pediatrics/Rady Children's Hospital San Diego, Department of Cellular &Molecular Medicine, Stem Cell Program, La Jolla, CA 92093, MC 0695, USA. FAU - Muotri, Alysson R AU - Muotri AR AD - University of California San Diego, School of Medicine, Department of Pediatrics/Rady Children's Hospital San Diego, Department of Cellular &Molecular Medicine, Stem Cell Program, La Jolla, CA 92093, MC 0695, USA. LA - eng GR - DP2 OD006495/OD/NIH HHS/United States GR - 1-DP2-OD006495-01/OD/NIH HHS/United States PT - Journal Article PT - Research Support, N.I.H., Extramural PT - Research Support, Non-U.S. Gov't DEP - 20150505 PL - England TA - Sci Rep JT - Scientific reports JID - 101563288 RN - 0 (Culture Media, Conditioned) RN - 0 (NRG1 protein, human) RN - 0 (Neuregulin-1) RN - 103107-01-3 (Fibroblast Growth Factor 2) SB - IM MH - Algorithms MH - Batch Cell Culture Techniques/*methods MH - Cell Differentiation/physiology MH - Cell Line MH - Cell Proliferation/physiology MH - Culture Media, Conditioned/chemistry/metabolism MH - Fibroblast Growth Factor 2/chemistry/*metabolism MH - Humans MH - Models, Statistical MH - Neuregulin-1/chemistry/*metabolism MH - Pluripotent Stem Cells/*cytology/*physiology MH - *Research Design PMC - PMC4419516 EDAT- 2015/05/06 06:00 MHDA- 2016/02/26 06:00 PMCR- 2015/05/05 CRDT- 2015/05/06 06:00 PHST- 2014/10/23 00:00 [received] PHST- 2015/03/17 00:00 [accepted] PHST- 2015/05/06 06:00 [entrez] PHST- 2015/05/06 06:00 [pubmed] PHST- 2016/02/26 06:00 [medline] PHST- 2015/05/05 00:00 [pmc-release] AID - srep09834 [pii] AID - 10.1038/srep09834 [doi] PST - epublish SO - Sci Rep. 2015 May 5;5:9834. doi: 10.1038/srep09834.